🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at residence.

After moments of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Information and Pricing

Inside these communities, posts display black plastic parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious medical dangers”.